Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
News Type
News Topics
- (-) Biomedical (2)
- (-) Space Exploration (1)
- 3-D Printing/Advanced Manufacturing (1)
- Advanced Reactors (1)
- Bioenergy (1)
- Composites (1)
- Computer Science (1)
- Fusion (1)
- Isotopes (2)
- Materials Science (2)
- Molten Salt (3)
- Nanotechnology (1)
- Neutron Science (4)
- Nuclear Energy (6)
- Physics (1)
- Transportation (1)
Media Contacts
A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.